AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-37002813_ITM" title="Facts and information about Oncolytics Biotech Announces Issuance of 31st United States Patent.">Oncolytics Biotech Announces Issuance of 31st United States Patent.</a>
Close
Set up an RSS feed that alerts you when new articles from BIOTECH Patent News are available.
Frequently asked questions about RSS feeds
Oncolytics Biotech Announces Issuance of 31st United States Patent.
Oncolytics Biotech, Inc. (Calgary, Canada) announced that it has been granted its 31st United States Patent 7,476,382, entitled "Reovirus for the Treatment of Neoplasia." The patent includes claims to pharmaceutical compositions containing reovirus.
"This United States patent expands and strengthens our proprietary position for REOLYSIN," said Mary Ann Dillahunty, Vice President of Intellectual Property for Oncolytics. "The pharmaceutical composition claims cover the ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Oncolytics Biotech announces issuance of 21th United States patent.
- Newspaper article from: BIOTECH Patent News May 1, 2007 700+ words
Oncolytics Biotech, Inc. (Calgary, Canada) has been granted United States Patent 7,223,585 entitled "Viral...combination with radiation or chemotherapy. Oncolytics Biotech, Inc. +1-403-670-7377 www...
- Oncolytics Biotech announces issuance of 23rd United States patent.
- Newspaper article from: BIOTECH Patent News August 1, 2007 700+ words
Oncolytics Biotech, Inc. (Calgary, Canada) has been granted United States Patent 7,264,798 entitled "Sensitization...combination with radiation or chemotherapy. Oncolytics Biotech, Inc. +1-403-670-7377 www...
- Oncolytics Biotech announces issuance of 18th United States patent.
- Newspaper article from: BIOTECH Patent News February 1, 2007 700+ words
Oncolytics Biotech Inc. (Calgary, Canada) has been granted United States Patent 7,163,678 entitled "Reovirus for...combination with radiation or chemotherapy. Oncolytics Biotech Inc. +1-403-670-7377
- Oncolytics Biotech obtains United States patent.(Brief Article)
- Newspaper article from: BIOTECH Patent News March 1, 2004 700+ words
Oncolytics Biotech, Inc. (Calgary, Canada) has patented a simple and efficient method of producing mammalian reovirus is developed using HEK...
- Oncolytics Biotech obtains United States patent.
- Newspaper article from: BIOTECH Patent News May 1, 2008 700+ words
Oncolytics Biotech, Inc. (Calgary, Canada) has patented methods for treating proliferative disorders, by administering reovirus to a Ras-mediated...
- Oncolytics Biotech obtains patent covering treatment of ras-mediated...
- Newspaper article from: BIOTECH Patent News September 1, 2002 700+ words
Oncolytics Biotech, Inc. (Calgary, Canada) has been granted United States Patent 6,455,038 entitled "Reovirus...recurrent malignant glioma trial. Oncolytics Biotech Inc. 403) 670-7377 www.oncolyticsbiotech...
- Oncolytics Biotech granted Ras targeted adenovirus patent.(Brief Article)
- Newspaper article from: BIOTECH Patent News July 1, 2003 700+ words
Oncolytics Biotech, Inc. (Calgary, Canada) announced that it has been granted United States patent 6,596,268 entitled "Viruses...in tumors injected with REOLYSIN. Oncolytics Biotech Inc. +1-403-670-7377 www...
- Oncolytics Biotech granted Ras targeted herpes virus patent.(Brief Article)
- Newspaper article from: BIOTECH Patent News November 1, 2003 700+ words
Oncolytics Biotech, Inc. (Calgary, Canada) announced that it has been granted United States Patent 6,649,157 entitled...tumors injected with REOLYSIN. Oncolytics Biotech, Inc. 403-670-7377 www.oncolyticsbiotech...
- Oncolytics Biotech announces issuance of 25th patent.
- Newspaper article from: BIOTECH Patent News November 1, 2007 700+ words
Oncolytics Biotech, Inc. (Calgary, Canada) announced that it has been granted United States Patent 7,306,902 entitled...with radiation or chemotherapy. Oncolytics Biotech, Inc. +1-403-670-7377 www...
- Oncolytics announces issuance of reovirus patent.(Oncolytics Biotech Inc. gets...
- Newspaper article from: BIOTECH Patent News May 1, 2003 700+ words
Oncolytics Biotech, Inc. (Calgary, Canada...announced that it has been granted United States Patent 6,565,831 entitled...tumours injected with REOLYSIN. Oncolytics Biotech, Inc. +1-403-670-7377 www...
Source: HighBeam Research, Oncolytics Biotech Announces Issuance of 31st United States Patent.